Childhood ObesityNCT06170853
The Effect of Exercise With AR Glasses on Metabolic Parameters and Anthropometric Measurements in Obese Adolescents
A study testing Exercise with augmented reality glasses in people with Childhood Obesity, run by TC Erciyes University at 1 site in Turkey (Türkiye).
Trial summary
This study was planned as a randomized controlled experimental study to determine the effect of exercise with Augmented Reality Goggles (AR) on metabolic parameters and anthropometric measurement values in obese children aged 10-19 years. Read more about this study
- Who is it for?
- Ages 10 to 19 years
- Conditions the study is for
- Childhood Obesity
- What is being tested?
- Exercise with augmented reality glasses
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 20 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 1 Dec 2023to 1 Jun 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 10 to 19 years
- All sexes
- No healthy volunteers
- Child, Adult
Who may be able to join
- Those between the ages of 10-19,
- Having been diagnosed with childhood obesity at least six months ago,
- Do not have any other chronic disease,
- No psychiatric diagnosis,
- No orthopedic problems,
- Able to read and write
Show all 10Show fewer
- Can speak Turkish,
- No mental, physical or neurological disability,
- Residing in the province where the research will be conducted,
- Children and children with parental consent to participate in the study will be included in the study.
Who cannot join
- -
Trial locations and contacts
1 site in 1 country.
About this study
This study was planned as a randomized controlled experimental study to determine the effect of exercise with Augmented Reality Goggles (AR) on metabolic parameters and anthropometric measurement values in obese children aged 10-19 years. The study will be conducted with children diagnosed with obesity between the ages of 10-19 years who are followed up in the Pediatric Endocrinology Outpatient Clinic of Erciyes University Health Application and Research Center Fevzi Mercan-Mustafa Eraslan Children's Hospital. According to the sample calculation, a total of 20 obese children aged 10-19 years (AR exercise group=10 and control group=10) will be included in the sample of the study. The data of the study will be collected using the Descriptive Characteristics Form for Obese Children and Their Families, Serum and Urine Biochemistry Values Form, Anthropometric Measurement Values Form, Augmented Reality Goggles, Body Composition Analyzer, Caliper, Tape Measure and Digital Height and Weight Measurement Device. Ethics committee permission was obtained from "Erciyes University Clinical Research Ethics Committee" and institutional permission was obtained from ERU Health Practice and Research Center Mustafa Eraslan Fevzi Mercan Children's Hospital. Hypothesis tests, correlation and regression analyzes will be applied according to the suitability of the data for normal distribution. As a result of the study, it is expected that exercise application with AR glasses will improve metabolic parameters and anthropometric measurement values in obese children.
Read the detailed description
Obesity, which is one of the major health problems in both developed and developing countries today, is a health problem that occurs with an increase in adipose tissue when energy intake is higher than energy consumption and can cause social, psychological and serious medical problems. If current trends continue, it is reported that 70 million children may be obese and overweight by 2025 and obesity will be a leading health problem. Childhood obesity increases in the first year of life, between 5-6 years of age and during puberty. 1/3 of obese children and 80% of obese adolescents remain obese when they reach adulthood. On the other hand, it is known that 30% of adult obesity cases date back to childhood. It has been reported that obesity affects 10.9-20.0% of all children and adolescents. In a study involving 5206 school-age children (mean age 8.6±1.2 years, 50.2% boys) from seven European countries (Turkey, Bulgaria, Romania, Lithuania, Germany, Italy and the Netherlands), it was reported that the prevalence of obesity in Turkish children was 7.7%, the second highest in Europe after Romania. Obesity in childhood has many medical adverse effects on children. Obesity may cause problems such as rapid growth, early menstruation, increase in blood lipids, increase in heart rate and heart rate volume, fatty liver, impaired sugar metabolism, hypertension, increase in white adipose tissue, increase in serum irisin, myonectin, triglyceride, total cholesterol and leptin levels and decrease in omentin-1 levels. In studies conducted in obese and healthy children, it was found that triglyceride, total cholesterol, irisin, low density lipoprotein (LDL-C) and leptin concentrations were higher in obese children compared to healthy children and omentin-1 levels were lower. Considering that childhood obesity continues into adulthood and brings many problems, the importance of combating obesity in this period is clearly seen. Reducing calorie intake, increasing exercise and providing psychosocial support are very important in the fight against obesity. While exercise constitutes a part of the standard treatment of obesity, it has been reported to be more effective than diet because it increases energy expenditure. In studies conducted in obese children, it was found that planned and long-term moderate exercise increased serum irisin, myonectin, omentin-1 and HDL concentrations and decreased serum leptin, triglyceride, total cholesterol and LDL concentrations. It has also been reported that exercise reduces metabolic and cardiovascular complications and improves body composition, cardiovascular health and mental health. Despite the numerous benefits of exercise, it has been reported that regular exercise habits are low in obese children. It has been reported that obese children cannot exercise regularly due to reasons such as low motivation, parents' inability to spare time to spend time with their children, children who are overwhelmed between courses/courses in the exam marathon with career anxiety, lack of emotional support and inability to give up existing habits. In this direction, exercise that requires continuity in the management of childhood obesity can be made dynamic for obese children by using different approaches. Therefore, it is thought that structured exercise with augmented reality glasses (AR) that can respond to the reactions of the obese child will be more dynamic, improve metabolic and anthropometric values and prevent macrovascular complications that may develop in obese children. This study was planned as a randomized controlled experimental study to determine the effect of exercise with AR glasses on metabolic parameters and anthropometric measurement values in obese children aged 10-19 years.
- Conditions
- Childhood Obesity
- Being tested
- Exercise with augmented reality glasses
- Keywords
- Childhood Obesity, Adolescent, Metabolic Parameters, Augmented Reality Glasses, Anthropometric Values
- Medical subject headings
- Pediatric Obesity
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Exercise with augmented reality glassesOther
Three days a week (12 weeks in total), each session will be 60 minutes in total, and moderate exercise will be done with AR glasses.
| Study group | Role | What they receive |
|---|---|---|
| Augmented reality glasses group | Experimental | Three days a week (12 weeks in total), each session will be 60 minutes in total, and moderate exercise will be done with AR glasses. Receives: Other: Exercise with augmented reality glasses |
| Control group | No intervention | No intervention/application will be made to the children who will be included in the control group. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in serum leptin levels
Serum leptin of children with type 1 diabetes before, during, after exercise and during the control session.
Measured: Change in average serum leptin over 12-week sessions
Change in serum irisin levels
Serum irisin of children with type 1 diabetes before, during, after exercise and during the control session.
Measured: Change in average serum irisin over 12-week sessions
Change in body mass index
Average body mass index values of children with obesity before, during, after exercise and during the control session.
Measured: Change in average body mass index over 12-week sessions
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted14 Dec 2023
- Study start1 Dec 2023
- Primary completion5 Dec 2024
- Study completion1 Jun 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Childhood ObesityStudies of the same condition, open and under way.
- More trials run by TC Erciyes UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Quadruple blind
- Who is masked
- Participant, Care provider, Investigator, Outcomes assessor
- Enrolment
- 20 participants (actual)
Sponsor and investigators
- Lead sponsor
- TC Erciyes University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Harun Özbey, TC Erciyes University
- Investigators
- Meral Bayat, PhD, Principal investigator, TC Erciyes University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06170853
- Sponsor's protocol ID
- 2023/198
- Status last verified
- May 2026
- First submitted
- 6 Dec 2023
- Last updated
- 18 May 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 18 May 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Effect of Exercise With AR Glasses on Metabolic Parameters and Anthropometric Measurements in Obese Adolescents
- ClinicalTrials.gov ID
- NCT06170853
- Acronym / sponsor ID
- 2023/198
- Conditions
- Childhood Obesity
- Keywords
- Childhood Obesity, Adolescent, Metabolic Parameters, Augmented Reality Glasses, Anthropometric Values
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 20 participants (actual)
- Lead sponsor
- TC Erciyes UniversityUniversity, hospital or other
- Study start
- 1 Dec 2023 (actual)
- Primary completion
- 5 Dec 2024 (actual)
- Study completion
- 1 Jun 2025 (actual)
- First posted
- 14 Dec 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study was planned as a randomized controlled experimental study to determine the effect of exercise with Augmented Reality Goggles (AR) on metabolic parameters and anthropometric measurement values in obese children aged 10-19 years. The study will be conducted with children diagnosed with obesity between the ages of 10-19 years who are followed up in the Pediatric Endocrinology Outpatient Clinic of Erciyes University Health Application and Research Center Fevzi Mercan-Mustafa Eraslan Children's Hospital. According to the sample calculation, a total of 20 obese children aged 10-19 years (AR exercise group=10 and control group=10) will be included in the sample of the study. The data of the study will be collected using the Descriptive Characteristics Form for Obese Children and Their Families, Serum and Urine Biochemistry Values Form, Anthropometric Measurement Values Form, Augmented Reality Goggles, Body Composition Analyzer, Caliper, Tape Measure and Digital Height and Weight Measurement Device. Ethics committee permission was obtained from "Erciyes University Clinical Research Ethics Committee" and institutional permission was obtained from ERU Health Practice and Research Center Mustafa Eraslan Fevzi Mercan Children's Hospital. Hypothesis tests, correlation and regression analyzes will be applied according to the suitability of the data for normal distribution. As a result of the study, it is expected that exercise application with AR glasses will improve metabolic parameters and anthropometric measurement values in obese children.
Detailed description
Obesity, which is one of the major health problems in both developed and developing countries today, is a health problem that occurs with an increase in adipose tissue when energy intake is higher than energy consumption and can cause social, psychological and serious medical problems. If current trends continue, it is reported that 70 million children may be obese and overweight by 2025 and obesity will be a leading health problem. Childhood obesity increases in the first year of life, between 5-6 years of age and during puberty. 1/3 of obese children and 80% of obese adolescents remain obese when they reach adulthood. On the other hand, it is known that 30% of adult obesity cases date back to childhood. It has been reported that obesity affects 10.9-20.0% of all children and adolescents. In a study involving 5206 school-age children (mean age 8.6±1.2 years, 50.2% boys) from seven European countries (Turkey, Bulgaria, Romania, Lithuania, Germany, Italy and the Netherlands), it was reported that the prevalence of obesity in Turkish children was 7.7%, the second highest in Europe after Romania. Obesity in childhood has many medical adverse effects on children. Obesity may cause problems such as rapid growth, early menstruation, increase in blood lipids, increase in heart rate and heart rate volume, fatty liver, impaired sugar metabolism, hypertension, increase in white adipose tissue, increase in serum irisin, myonectin, triglyceride, total cholesterol and leptin levels and decrease in omentin-1 levels. In studies conducted in obese and healthy children, it was found that triglyceride, total cholesterol, irisin, low density lipoprotein (LDL-C) and leptin concentrations were higher in obese children compared to healthy children and omentin-1 levels were lower. Considering that childhood obesity continues into adulthood and brings many problems, the importance of combating obesity in this period is clearly seen. Reducing calorie intake, increasing exercise and providing psychosocial support are very important in the fight against obesity. While exercise constitutes a part of the standard treatment of obesity, it has been reported to be more effective than diet because it increases energy expenditure. In studies conducted in obese children, it was found that planned and long-term moderate exercise increased serum irisin, myonectin, omentin-1 and HDL concentrations and decreased serum leptin, triglyceride, total cholesterol and LDL concentrations. It has also been reported that exercise reduces metabolic and cardiovascular complications and improves body composition, cardiovascular health and mental health. Despite the numerous benefits of exercise, it has been reported that regular exercise habits are low in obese children. It has been reported that obese children cannot exercise regularly due to reasons such as low motivation, parents' inability to spare time to spend time with their children, children who are overwhelmed between courses/courses in the exam marathon with career anxiety, lack of emotional support and inability to give up existing habits. In this direction, exercise that requires continuity in the management of childhood obesity can be made dynamic for obese children by using different approaches. Therefore, it is thought that structured exercise with augmented reality glasses (AR) that can respond to the reactions of the obese child will be more dynamic, improve metabolic and anthropometric values and prevent macrovascular complications that may develop in obese children. This study was planned as a randomized controlled experimental study to determine the effect of exercise with AR glasses on metabolic parameters and anthropometric measurement values in obese children aged 10-19 years.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Quadruple blind (participant, care provider, investigator, outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Augmented reality glasses group | Experimental | Other: Exercise with augmented reality glassesThree days a week (12 weeks in total), each session will be 60 minutes in total, and moderate exercise will be done with AR glasses. |
| Control group | No intervention | –No intervention/application will be made to the children who will be included in the control group. |
Who may qualify
- Ages
- 10 to 19 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult
Key inclusion criteria (10 listed)
- Those between the ages of 10-19,
- Having been diagnosed with childhood obesity at least six months ago,
- Do not have any other chronic disease,
- No psychiatric diagnosis,
- No orthopedic problems,
Key exclusion criteria (1 listed)
- -
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Exercise with augmented reality glassesThree days a week (12 weeks in total), each session will be 60 minutes in total, and moderate exercise will be done with AR glasses. | Other | Augmented reality glasses group |
Primary outcome
Change in serum leptin levels
Time frame: Change in average serum leptin over 12-week sessions
Serum leptin of children with type 1 diabetes before, during, after exercise and during the control session.
Change in serum irisin levels
Time frame: Change in average serum irisin over 12-week sessions
Serum irisin of children with type 1 diabetes before, during, after exercise and during the control session.
Change in body mass index
Time frame: Change in average body mass index over 12-week sessions
Average body mass index values of children with obesity before, during, after exercise and during the control session.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 18 May 2026.
- Individual participant dataSharing planned: No
Related trials for Childhood Obesity
Not yet recruiting
Effectiveness of a 10-week Multicomponent Intervention Combined With Parent Education on Binge Eating Behavior in Children and Adolescents
Binge Eating Disorder, Binge Eating
Recruiting
National Childhood Obesity Prevention Programme BE FIT 24
Childhood Obesity
RecruitingPhase 2
Oxytocin for Weight Loss in Adolescents
Obesity, Adolescent, Oxytocin
Not yet recruitingObservational study
Brain and Obesity Longitudinal Development: Neurobiological Mechanisms of Semaglutide Treatment of Adolescent Obesity
Pediatric Obesity, Obesity
RecruitingObservational study
Early Tracking of Childhood Health Determinants (ETCHED) Study
Diabetes Mellitus, Obesity
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Meral Bayat, PhD principal investigator
TC Erciyes University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Exercise with augmented reality glasses in people with Childhood Obesity, run by TC Erciyes University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 10 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 18 May 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in serum leptin levels (time frame: Change in average serum leptin over 12-week sessions). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 May 2026.